Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rossert, J. A.
Right arrow Articles by Wauters, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossert, J. A.
Right arrow Articles by Wauters, J.-P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 19-28
© 2002 European Renal Association-European Dialysis and Transplant Association


Recommendations for the screening and management of patients with chronic kidney disease

Jérôme A. Rossert1, and Jean-Pierre Wauters2

1 Division of Nephrology, Tenon Hospital (AP-HP), INSERM U489, and Pierre and Marie Curie University, Paris, France and 2 Division of Nephrology, University Hospital, Lausanne, Switzerland

Abstract

End-stage renal disease (ESRD) is a major health problem associated with considerable increase in morbidity and mortality and with decreased quality of life. To slow the progression of kidney failure, to prevent the consequences of chronic kidney disease (CKD) and to decrease cardiovascular mortality associated with CKD, it is crucial to detect patients with CKD early and to optimize their care. To assist physicians in patient management, members of a working party for the management of CKD have identified several recommendations for the screening of patients at risk of CKD and for the management of patients with established CKD.

Keywords: chronic kidney disease; management prevention; progression; screening

Notes

Correspondence and offprint requests to: Jérôme Rossert, Department of Nephrology, Tenon Hospital, 4 Rue de la Chine, 75970 Paris Cedex 20, France. Tel: +33156016029, fax: +33156016999, e-mail: jerome.rossert{at}tnn.ap\|[hyphen]\|hop\|[hyphen]\|paris.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
L. A. Rocha, D. V. Barreto, F. C. Barreto, C. B. Dias, R. Moyses, M. R. R. Silva, L. A. R. Moura, S. A. Draibe, V. Jorgetti, A. B. Carvalho, et al.
Serum Ferritin Level Remains a Reliable Marker of Bone Marrow Iron Stores Evaluated by Histomorphometry in Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 105 - 109.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. Q Hudson
Secondary Hyperparathyroidism in Chronic Kidney Disease: Focus on Clinical Consequences and Vitamin D Therapies
Ann. Pharmacother., September 1, 2006; 40(9): 1584 - 1593.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.